Published in J Natl Cancer Inst on March 20, 2002
Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA (2008) 5.66
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol (2007) 5.23
Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31. J Clin Oncol (2009) 3.86
The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol (2014) 2.07
Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med (2004) 1.81
Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer (2011) 1.62
Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer? Eur Urol (2012) 1.55
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. BMC Cancer (2008) 1.54
Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer (2010) 1.41
What happened? Sexual consequences of prostate cancer and its treatment. Can Fam Physician (2005) 1.15
Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control (2009) 1.12
Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications. Ann Oncol (2012) 1.04
Androgen deprivation and cognition in prostate cancer. Br J Cancer (2003) 1.04
Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215. J Sex Med (2011) 1.00
Best practice in primary care pathology: review 4. J Clin Pathol (2006) 1.00
Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study. Cancer (2012) 0.97
Impact of androgen deprivation therapy on sexual function. Asian J Androl (2012) 0.92
Marital satisfaction of advanced prostate cancer survivors and their spousal caregivers: the dyadic effects of physical and mental health. Psychooncology (2010) 0.85
Androgen deprivation as primary treatment for early prostate cancer: should we "just do something"? J Natl Cancer Inst (2002) 0.84
Management of complications of androgen deprivation therapy in the older man. Crit Rev Oncol Hematol (2008) 0.83
National survey addressing the information needs of primary care physicians: Side effect management of patients on androgen deprivation therapy. Can Urol Assoc J (2014) 0.83
Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues. Indian J Urol (2009) 0.82
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art. Cancer Manag Res (2010) 0.81
Prostate cancer testing following a negative prostate biopsy: over testing the elderly. J Gen Intern Med (2007) 0.78
The primary health care physician and the cancer patient: tips and strategies for managing sexual health. Transl Androl Urol (2015) 0.75
Personalized medicine in Europe: not yet personal enough? BMC Health Serv Res (2017) 0.75
A brief assessment of physical functioning for prostate cancer patients. Patient Relat Outcome Meas (2010) 0.75
The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer. J Geriatr Oncol (2013) 0.75
Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Cancer Med (2016) 0.75
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4. Nat Clin Pract Urol (2009) 0.75
Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings. Patient (2017) 0.75
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14
Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med (2013) 7.95
Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res (2006) 7.67
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst (2009) 6.07
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA (2012) 5.90
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst (2004) 5.84
Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA (2008) 5.66
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57
Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol (2008) 4.72
Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics. N Engl J Med (2015) 4.58
Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med (2009) 4.44
Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol (2012) 4.24
Prostate specific antigen best practice statement: 2009 update. J Urol (2009) 3.95
Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer (2002) 3.89
Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. Arch Intern Med (2010) 3.85
Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst (2013) 3.81
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet (2005) 3.69
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58
Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet (2009) 3.41
Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25
Active surveillance for early-stage prostate cancer: review of the current literature. Cancer (2008) 3.18
Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol (2012) 3.12
Applying item response theory (IRT) modeling to questionnaire development, evaluation, and refinement. Qual Life Res (2007) 3.10
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer (2002) 3.05
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol (2007) 2.97
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol (2009) 2.95
Evaluation of the Healthy Eating Index-2005. J Am Diet Assoc (2008) 2.93
Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82
Health effects of the 2003 Southern California wildfires on children. Am J Respir Crit Care Med (2006) 2.81
Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol (2008) 2.79
Developing tailored instruments: item banking and computerized adaptive assessment. Qual Life Res (2007) 2.76
5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol (2005) 2.72
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care (2012) 2.70
Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol (2005) 2.67
A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol (2003) 2.56
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res (2002) 2.56
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes Control (2009) 2.49
Circumcision and the risk of prostate cancer. Cancer (2012) 2.48
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res (2011) 2.42
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet (2012) 2.18
Birth outcomes and prenatal exposure to ozone, carbon monoxide, and particulate matter: results from the Children's Health Study. Environ Health Perspect (2005) 2.17
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol (2008) 2.16
Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev (2007) 2.11
Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma. Thorax (2007) 2.10
Carbonated soft drink consumption and risk of esophageal adenocarcinoma. J Natl Cancer Inst (2006) 2.08
What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health (2007) 2.06
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res (2005) 2.02
Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01
Recent evidence for adverse effects of residential proximity to traffic sources on asthma. Curr Opin Pulm Med (2008) 2.00
Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest (2005) 1.98
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet (2005) 1.96
General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol (2003) 1.91
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol (2010) 1.86
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care (2012) 1.84
Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol (2007) 1.84
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate (2009) 1.83
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82